AEYE Health vs CytoReason
AEYE Health vs CytoReason, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AEYE Health is on 56/100 and CytoReason on 68/100.
Where each one leads
AEYE Health
- agent readiness: 45/100 against 21/100
- headcount growth: +33.6% against +13.7%
CytoReason
- our overall score: 68/100 against 56/100
- domain rating: 40/100 against 27/100
- headcount: 116 against 39
- funding raised: $128M against $4.0M
- LinkedIn following: 12,830 against 6,538
At a glance
| Measure | AEYE Health | CytoReason |
|---|---|---|
| What it is | AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Optometry, Retinal Screening Ophthalmology, Diabetic Retinopathy | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware, Software | Software |
| Founded | 2016 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | AEYE Health | CytoReason |
|---|---|---|
| Employees | 39 | 116 |
| Headcount growthLast 12 months | +33.6% | +13.7% |
| Total funding | $4.0M | $128M |
| Latest round | Seed | Series B |
| LinkedIn followers | 6,538 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AEYE Health | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 68/100 |
| Traction | 49/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 42/100 | 30/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 27/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AEYE Health | CytoReason |
|---|---|---|
| CMS | Wix | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Segment |
AEYE Health vs CytoReason: common questions
Which is better, AEYE Health or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do AEYE Health and CytoReason compare on the numbers?
AEYE Health leads on agent readiness (45/100 against 21/100), headcount growth (+33.6% against +13.7%). CytoReason leads on our overall score (68/100 against 56/100), domain rating (40/100 against 27/100), headcount (116 against 39), funding raised ($128M against $4.0M), LinkedIn following (12,830 against 6,538).
Read the full AEYE Health review and pricing or the CytoReason review and pricing. You can also browse other AEYE Health alternatives we track.